Markus S. Anker

5.6k total citations
68 papers, 1.9k citations indexed

About

Markus S. Anker is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Markus S. Anker has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 23 papers in Physiology and 16 papers in Molecular Biology. Recurrent topics in Markus S. Anker's work include Heart Failure Treatment and Management (23 papers), Nutrition and Health in Aging (21 papers) and Chemotherapy-induced cardiotoxicity and mitigation (19 papers). Markus S. Anker is often cited by papers focused on Heart Failure Treatment and Management (23 papers), Nutrition and Health in Aging (21 papers) and Chemotherapy-induced cardiotoxicity and mitigation (19 papers). Markus S. Anker collaborates with scholars based in Germany, United States and Italy. Markus S. Anker's co-authors include Stephan von Haehling, Stefan D. Anker, Jochen Springer, Andrew J.S. Coats, Alessia Lena, Ulf Landmesser, Wolfram Doehner, Mitja Lainščak, Wilhelm Haverkamp and Javed Butler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Markus S. Anker

60 papers receiving 1.8k citations

Peers

Markus S. Anker
Natalie Daya United States
K.C.H. Fearon United Kingdom
Amrut V. Ambardekar United States
Markus S. Anker
Citations per year, relative to Markus S. Anker Markus S. Anker (= 1×) peers Yoichiro Otaki

Countries citing papers authored by Markus S. Anker

Since Specialization
Citations

This map shows the geographic impact of Markus S. Anker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus S. Anker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus S. Anker more than expected).

Fields of papers citing papers by Markus S. Anker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus S. Anker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus S. Anker. The network helps show where Markus S. Anker may publish in the future.

Co-authorship network of co-authors of Markus S. Anker

This figure shows the co-authorship network connecting the top 25 collaborators of Markus S. Anker. A scholar is included among the top collaborators of Markus S. Anker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus S. Anker. Markus S. Anker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butler, Javed, Muhammad Shahzeb Khan, Tim Friede, et al.. (2025). Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trial. European Heart Journal.
2.
Khouri, Michel G., Markus S. Anker, Michael E. Hall, et al.. (2024). Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020. American Heart Journal. 278. 170–180. 2 indexed citations
3.
Anker, Markus S., Jan Porthun, Guillaume Bonnet, et al.. (2024). Percutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure. Journal of the American College of Cardiology. 84(24). 2364–2368. 15 indexed citations
4.
Anker, Markus S., Ahmed Mustafa Rashid, Javed Butler, & Muhammad Shahzeb Khan. (2024). Cardiac wasting in patients with cancer. Basic Research in Cardiology. 120(1). 25–34. 4 indexed citations
5.
Korste, Sebastian, Stephan Settelmeier, Lars Michel, et al.. (2023). Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart. International Journal of Molecular Sciences. 24(7). 6052–6052. 4 indexed citations
6.
Evertz, Ruben, Miroslava Valentová, Tobias R. Overbeck, et al.. (2023). Predictors of lower exercise capacity in patients with cancer. Scientific Reports. 13(1). 14861–14861. 1 indexed citations
7.
Evertz, Ruben, Miroslava Valentová, Friederike Braulke, et al.. (2022). Cardiovascular and Metabolic Determinants of Quality of Life in Patients with Cancer. ESC Heart Failure. 10(1). 167–176. 4 indexed citations
8.
Doltra, Adelina, Bernhard Schnackenburg, Alexander Berger, et al.. (2021). Long-Term Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance in Patients with Atrial Fibrillation. ESC Heart Failure. 9(1). 110–121. 4 indexed citations
9.
Anker, Markus S., Sara Hadzibegovic, Alessia Lena, et al.. (2019). Recent Advances in Cardio-Oncology: A Report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’. ESC Heart Failure. 6(6). 1140–1148. 31 indexed citations
10.
Heckmann, Markus, Daniel Finke, Markus S. Anker, et al.. (2019). Evidence for a Cardiac Metabolic Switch in Patients with Hodgkin's Lymphoma. ESC Heart Failure. 6(4). 824–829. 13 indexed citations
11.
Anker, Markus S., Sara Hadzibegovic, Alessia Lena, & Wilhelm Haverkamp. (2019). The Difference in Referencing in Web of Science, Scopus, and Google Scholar. ESC Heart Failure. 6(6). 1291–1312. 47 indexed citations
12.
Lena, Alessia, Andrew J.S. Coats, & Markus S. Anker. (2018). Metabolic Disorders in Heart Failure and Cancer. ESC Heart Failure. 5(6). 1092–1098. 32 indexed citations
13.
Anker, Markus S., Alessia Lena, Sara Hadzibegovic, et al.. (2018). Modern-Day Cardio-Oncology: A Report from the ‘Heart Failure and World Congress on Acute Heart Failure 2018’. ESC Heart Failure. 5(6). 1083–1091. 16 indexed citations
14.
Palus, Sandra, Wolfram Doehner, S. von Haehling, et al.. (2017). Models of sarcopenia: Short review. International Journal of Cardiology. 238. 19–21. 36 indexed citations
15.
Ishida, Junichi, Masakazu Saitoh, Wolfram Doehner, et al.. (2017). Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results. International Journal of Cardiology. 238. 12–18. 23 indexed citations
16.
Tsimploulis, Apostolos, Helen Sheriff, Phillip H. Lam, et al.. (2017). Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study. International Journal of Cardiology. 235. 11–16. 19 indexed citations
17.
Anker, Markus S., Stephan von Haehling, Jochen Springer, Maciej Banach, & Stefan D. Anker. (2013). State of the art paper Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Archives of Medical Science. 1. 166–171. 25 indexed citations
18.
Bang, Claudia, Anika Tschirner, Volker Adams, et al.. (2013). TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy. International Journal of Cardiology. 168(2). 1447–1452. 42 indexed citations
19.
Anker, Markus S., Stephan von Haehling, Jochen Springer, Maciej Banach, & Stefan D. Anker. (2012). Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. International Journal of Cardiology. 162(2). 73–76. 23 indexed citations
20.
Haehling, Stephan von, Markus S. Anker, Ewa A. Jankowska, Piotr Ponikowski, & Stefan D. Anker. (2011). Anemia in chronic heart failure: Can we treat? What to treat?. Heart Failure Reviews. 17(2). 203–210. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026